Estimation of binding affinities for selective thrombin inhibitors via Monte Carlo simulations

被引:44
作者
Pierce, AC [1 ]
Jorgensen, WL [1 ]
机构
[1] Yale Univ, Dept Chem, New Haven, CT 06520 USA
关键词
D O I
10.1021/jm000405u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Monte Carlo simulations have been performed on a series of 20 active-site-directed thrombin inhibitors to determine the interactions and energetics associated with the binding of these compounds. Physicochemical descriptors of potential value in the prediction of binding affinities were averaged during simulations of each inhibitor unbound in water and bound to thrombin. Regression equations based on 3-5 descriptors are able to reproduce the experimental binding affinities, which cover a 7 kcal/mol range, with rms errors of 1.0-1.3 kcal/mol, and yield correlation coefficients, r(2), Of 0.7-0.8. On the basis of these results, the quantities most important in determining the binding affinities are: (1) the enhancement of van der Waals interactions in going from solution to the bound state, (2) the intramolecular strain induced in the inhibitor upon binding, (3) the number of hydrogen bonds lost in the binding process, and (4) the number of rotatable bonds in the inhibitor. The descriptors are physically reasonable and, in combination with the insights gained from analysis of the simulation structures, suggest directions for the development of improved thrombin inhibitors.
引用
收藏
页码:1043 / 1050
页数:8
相关论文
共 41 条
[21]  
JORGENSEN WL, 2000, BOSS VERSION 4 2
[22]  
JORGENSEN WL, 2000, MCPRO VERSION 1 65
[23]   Rational design of selective thrombin inhibitors [J].
Kim, S ;
Hwang, SY ;
Kim, YK ;
Yun, M ;
Oh, YS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (07) :769-774
[24]   Estimation of the binding affinities of FKBP12 inhibitors using a linear response method [J].
Lamb, ML ;
Tirado-Rives, J ;
Jorgensen, WL .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (05) :851-860
[25]   Benzylamine-based selective and orally bioavailable inhibitors of thrombin [J].
Lee, K ;
Jung, WH ;
Park, CW ;
Hong, CY ;
Kim, IC ;
Kim, S ;
Oh, YS ;
Kwon, OH ;
Lee, SH ;
Park, HD ;
Kim, SW ;
Lee, YH ;
Yoo, YJ .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (18) :2563-2568
[26]   Structural modification of an orally active thrombin inhibitor, LB30057: Replacement of the D-pocket-binding naphthyl moiety [J].
Lee, K ;
Hwang, SY ;
Hong, S ;
Hong, CY ;
Lee, CS ;
Shin, Y ;
Kim, S ;
Yun, M ;
Yoo, YJ ;
Kang, M ;
Oh, YS .
BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (06) :869-876
[27]   A general and fast scoring function for protein-ligand interactions: A simplified potential approach [J].
Muegge, I ;
Martin, YC .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (05) :791-804
[28]   Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor [J].
Oh, YS ;
Yun, M ;
Hwang, SY ;
Hong, S ;
Shin, Y ;
Lee, K ;
Yoon, KH ;
Yoo, YJ ;
Kim, DS ;
Lee, SH ;
Lee, YH ;
Park, HD ;
Lee, CH ;
Lee, SK ;
Kim, S .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (06) :631-634
[29]  
OH YS, 1996, Patent No. 739886
[30]   Computational binding studies of orthogonal cyclosporin-cyclophilin pairs [J].
Pierce, AC ;
Jorgensen, WL .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH, 1997, 36 (13-14) :1466-1469